Revolutionizing Drug Development: Small-Cap Stocks Harness the Power of AI
Revolutionizing Drug Development: Small-Cap Stocks Harness the Power of AI
As artificial intelligence (AI) continues to revolutionize various sectors, drug development stands out as a prime beneficiary. Projections indicate that by 2030, the global AI in drug discovery market is poised to reach a substantial $4.6 billion, expanding at an impressive compound annual growth rate …